SILLAJEN Trademark

Trademark Overview

On Tuesday, May 9, 2023, a trademark application was filed for SILLAJEN with the United States Patent and Trademark Office. The USPTO has given the SILLAJEN trademark a serial number of 97926910. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, June 3, 2026. This trademark is owned by SillaJen, Inc.. The SILLAJEN trademark is filed in the Pharmaceutical Products category with the following description:

Oncolytic viruses being biopharmaceutical agents for the prevention, diagnosis, and treatment of cancer; biologic pharmaceutical preparations for the prevention, diagnosis, and treatment of cancer

General Information

Serial Number97926910
Word MarkSILLAJEN
Filing DateTuesday, May 9, 2023
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, June 3, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 28, 2025

Trademark Statements

Goods and ServicesOncolytic viruses being biopharmaceutical agents for the prevention, diagnosis, and treatment of cancer; biologic pharmaceutical preparations for the prevention, diagnosis, and treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 7, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSillaJen, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeoul 04525
KR
Party NameSillaJen, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeoul 04525
KR

Trademark Events

Event DateEvent Description
Friday, May 12, 2023NEW APPLICATION ENTERED
Wednesday, June 7, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 8, 2023ASSIGNED TO EXAMINER
Thursday, September 14, 2023NON-FINAL ACTION WRITTEN
Thursday, September 14, 2023NON-FINAL ACTION E-MAILED
Thursday, September 14, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 14, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, December 14, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, January 12, 2024ASSIGNED TO EXAMINER
Tuesday, February 6, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 6, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 6, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 9, 2024SUSPENSION LETTER WRITTEN
Friday, February 9, 2024LETTER OF SUSPENSION E-MAILED
Friday, February 9, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, January 3, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 22, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 28, 2025PUBLISHED FOR OPPOSITION
Tuesday, January 28, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 25, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 23, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, September 23, 2025SOU EXTENSION 1 FILED
Wednesday, September 24, 2025SOU EXTENSION 1 GRANTED
Wednesday, September 24, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 17, 2025TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, March 18, 2026SOU TEAS EXTENSION RECEIVED
Tuesday, June 2, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, October 17, 2025DIVISIONAL REQUEST RECEIVED
Wednesday, June 3, 2026DIVISIONAL PROCESSING COMPLETE
Wednesday, June 3, 2026CORRECTED NOA E-MAILED
Wednesday, March 18, 2026SOU EXTENSION 2 FILED
Wednesday, June 3, 2026SOU EXTENSION 2 GRANTED
Thursday, June 4, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

sillajen treatment cancer diagnosis prevention biologic pharmaceutical preparations viruses being oncolytic